Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
753 studies found for:    "Urinary Bladder Neoplasms"
Show Display Options
Rank Status Study
1 Terminated Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer
Conditions: Urinary Bladder Diseases;   Urinary Bladder Neoplasms;   Urinary Bladder Cancer;   Malignant Tumor of Urinary Bladder;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Site
Interventions: Device: Synergo + MMC;   Drug: Bacillus Calmette-Guérin
2 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
3 Recruiting Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms
Condition: Urinary Bladder Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
4 Active, not recruiting Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer;   Bladder Neoplasms
Intervention:
5 Completed
Has Results
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Conditions: Carcinoma, Transitional Cell;   Bladder Cancer;   Bladder Neoplasm
Interventions: Drug: Pralatrexate Injection;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic Acid
6 Active, not recruiting Safety and Efficacy Study of Cancer Immunotherapeutic MAGE-A3 + AS-15 in Patients With Muscle-invasive Bladder Cancer After Cystectomy
Condition: Urinary Bladder Neoplasms
Interventions: Biological: recMAGE-A3 + AS15 ASCI;   Biological: Placebo
7 Terminated A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy
Conditions: Bladder Carcinoma;   Infiltrative Bladder Carcinoma;   Cystectomy
Intervention: Drug: LAPATINIB
8 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Radiation: 3D conformal radiation therapy
9 Completed Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Conditions: Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Procedure: Prostate capsule sparing cystectomy;   Procedure: Nerve sparing cystectomy
10 Completed Gene Therapy in Treating Patients With Advanced Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Intervention: Biological: Ad5CMV-p53 gene
11 Recruiting Confocal Microscopy Dual Band in the Management of Bladder Cancer
Condition: Urinary Bladder Neoplasm
Intervention: Device: Cellvizio dual band
12 Completed Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
Condition: Urinary Bladder Neoplasm
Intervention: Drug: Mitomycin C
13 Terminated
Has Results
Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage 0 Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Drug: broccoli sprout extract;   Other: laboratory biomarker analysis;   Other: Mango Juice
14 Terminated Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy
Conditions: Bladder Adenocarcinoma;   Bladder Squamous Cell Carcinoma;   Bladder Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Biological: Recombinant Fowlpox-TRICOM Vaccine;   Biological: Recombinant Fowlpox GM-CSF Vaccine Adjuvant;   Procedure: Therapeutic Conventional Surgery;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
15 Completed
Has Results
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: genistein;   Other: laboratory biomarker analysis;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study
16 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Sirolimus;   Procedure: Therapeutic Conventional Surgery
17 Recruiting MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Conditions: No Evidence of Disease;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IVA Bladder Cancer;   Stage IVB Bladder Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
18 Active, not recruiting Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Conditions: Distal Urethral Cancer;   Proximal Urethral Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
19 Not yet recruiting A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer
Conditions: Urinary Bladder Cancer;   Bladder Tumors;   Transitional Cell Carcinoma of the Bladder;   Malignant Melanoma;   Melanoma;   Skin Cancer;   Carcinoma, Non-Small-Cell Lung;   Lung Cancer
Interventions: Biological: NEO-PV-01;   Biological: Nivolumab;   Other: Adjuvant
20 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years